Mediators in Exhaled Breath Condensate after Hypertonic Saline Challenge

REFERENCES

• Mai X-M, Bottcher MF, Bruhammar M, Nilsson L, Zetterstrom O. Urinary inflammatory mediators and inhalation of hypertonic saline in children. Allergy 2005; 60:60–64.
   PubMed Web of Science ®Google Scholar
• Thomas PS, Yates DH, Barnes PJ. Sputum induction as a method of analyzing pulmonary cells: Reproducibility and acceptability. J. Asthma 1999; 36:335–341.
   PubMed Web of Science ®Google Scholar
• Jones PD, Hankin R, Simpson J, Gibson PG, Henry RL. The tolerability, safety, and success of sputum induction and combined hypertonic saline challenge in children. Am J Respir Crit Care Med 2001; 164:1146–1159.
   Google Scholar
• Belcher NG, Rees PJ, Clark TJ, Lee TH. A comparison of the refractory periods induced by hypertonic airway challenge and exercise in bronchial asthma. Am Rev Respir Dis 1987; 135:822–825.
   Google Scholar
• Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyper-responsiveness in asthma: Mechanisms, pharmacology and implications for clinical research. Eur Respir J 2000; 16:514–533.
   PubMed Web of Science ®Google Scholar
• Storms WW. Exercise-induced asthma: Diagnosis and treatment for the recreational or elite athlete. Med Sci Sports & Exerc 1999; 31(suppl):S33–38.
   Google Scholar
• Hunt JF. Exhaled breath condensate: An evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110:28–34.
   PubMed Web of Science ®Google Scholar
• Horváth I, Hunt J, Barnes PJ. Exhaled breath condensate: Methodological recommendations and unresolved questions. Eur Respir J 2005; 26:523–548.
   PubMed Web of Science ®Google Scholar
• Baraldi E, Ghiro L, Piovan V, Carraro S, Zaccello F, Zanconato S. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003; 88:358–360.
   PubMed Web of Science ®Google Scholar
• Ratnawati, Morton J, Henry RL, Thomas PS. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Ped Pulmonol 2006; 41: 929–936.
   PubMed Web of Science ®Google Scholar
• Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Hom S, Gaston B, Hunt J. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003; 22:889–894.
   PubMed Web of Science ®Google Scholar
• Jackson AS, Sandrini A, Campbell C, Thomas PS, Yates DH. Comparison of Biomarkers in Exhaled Breath Condensate and Bronchoalveolar Lavage. Am J Respir Crit Care Med 2007; 175:222–227.
   PubMed Web of Science ®Google Scholar
• van Beurden WJ, Harff GA, Dekhuijzen PN, van den Bosch MJ, Cre JP, Smeenk FW. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002; 96:197–203.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandines in asthma. J Allergy Clin Immunol 2002; 109:615–620.
   PubMed Web of Science ®Google Scholar
• Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58:505–509.
   PubMed Web of Science ®Google Scholar
• Antczak A, Kharitonov SA, Montuschi P, Gorski P, Barnes PJ. Inflammatory response to sputum induction measured by exhaled markers. Respiration 2005; 72:594–599.
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003; 21:589–593.
   PubMed Web of Science ®Google Scholar
• Gessner C, Kuhn H, Toepfer K, Hammerschmidt S, Schauer J, Wirtz H. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 2004; 43:215–222.
   PubMed Web of Science ®Google Scholar
• Schwartz LB, Bradford TR, Rouse C, . Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis. J Allergy Clin Immunol 1994; 14:190–204.
   Google Scholar
• Bettiol J, Radermecker M, Sele J, Henquet M, Cataldo D, Louis R. Airway mast cell activation in asthmatics is associated with selective sputum eosinophilia. Allergy 1999; 54:1188–1193.
   PubMed Web of Science ®Google Scholar
• Anonymous. Recommendations for Standardised Procedures for the Online and Offline Measurements of Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children-1999. Am J Respir Crit Care 1999; 160:2104–2117.
   PubMed Web of Science ®Google Scholar
• Hunter JA, Finkbeiner WE, Nadel JA, Goetzl EJ, Holtzman MJ. Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci USA 1985; 82:4633–4637.
   PubMed Web of Science ®Google Scholar
• Carpagnano G, Barbaro MPF, Cagnazzo M, Di Gioia G, Giliberti T, Di Matteo C, . Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge. Chest 2005; 128:3159–3166.
   PubMed Web of Science ®Google Scholar
• Anderson SD. Exercise-induced asthma and the use of hypertonic saline aerosol as a bronchial challenge. Respirology 1996; 3:175–181.
   Google Scholar
• Rogers DF. Airway goblet cells: Responsive and adaptable front-line defenders. Eur Respir J 1994; 7:1690–1706.
   PubMed Web of Science ®Google Scholar
• Greiff L, Andersson M, Wollmer P, Persson CGA. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo. Eur Respir J 2003; 21:308–312.
   PubMed Web of Science ®Google Scholar
• Kim KC. Biochemistry and pharmacology of mucin-like glycoproteins produced by cultured airway epithelial cells. Exp Lung Res 1991; 17:533–545.
   PubMed Web of Science ®Google Scholar
• Daviskas E, Anderson SD, Gonda I, Eberi S, Meikle S, Seale JP, Bautovich G. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J 1996; 9:725–732.
   PubMed Web of Science ®Google Scholar
• Gravelyn TH, Pan PM, Eschenbacher WL. Mediator release in an isolated airway segment in subjects with asthma. Am Rev Respir Dis 1988; 137:641–646.
   Google Scholar
• Maxwell DL, Hawksworth RJ, Lee TH. Inhaled nedocromil sodium reduces histamine release from isolated large airway segments of asthmatic subjects in vivo. Eur Respir J 1993; 6:1145–1150.
   Google Scholar
• Silber G, Proud D, Warner J. In vivo release of inflammatory mediators by hypertonic solutions. Am Rev Respir Dis 1988; 137:606–612.
   PubMed Web of Science ®Google Scholar
• Jongejan RC, de Jongste JC, Raatgeep HC, Bonta IL, Kerrebijn KF. Effects of changes in osmolarity on isolated human airways. J Appl Physiol 1990; 68:1568–1575.
   PubMed Web of Science ®Google Scholar
• Makker HK, Springall DR, Redington AE, Ghatei MA, Bloom SR, Polak JM, . Airway endothelin levels in asthma: Influence of endobronchial hypertonic saline challenge. Clin Exp Allergy 1999; 29:241–247.
   Google Scholar
• Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Kundu S, Zhang J. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997; 52:1030–1035.
   PubMed Web of Science ®Google Scholar
• Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA. Adenosine 5′-monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med 2004; 98:651–655.
   Google Scholar
• Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Increased interleukin-4 and decreased interferon- in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002; 165:1290–1293.
   PubMed Web of Science ®Google Scholar
• Jorens PG, Van Overveld FJ, Vermeire PA, Bult H, Herman AG. Synergism between interleukin-1 beta and interferon-gamma, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur J Pharmacol 1992; 224:7–12.
   PubMed Web of Science ®Google Scholar
• Ratnawati R, Thomas PS. Exhaled nitric oxide in paediatric asthma. Chron Respir Dis 2005; 2:163–174.
   Google Scholar
• de Gouw HWFM, Hendriks J, Woltman AM, Twiss IM, Sterk PJ. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med 1998; 158:315–319.
   PubMedGoogle Scholar
• Beier J, Beeh KM, Kornmann O, Buhl R. Sputum induction leads to a decrease of exhaled nitric oxide unrelated to airflow. Eur Respir J 2003; 22:354–357.
   Google Scholar
• Deykin A, Massaro AF, Coulston E, Drazen JM, Israel E. Exhaled nitric oxide following repeated spirometry or repeated plethysmography in healthy individuals. Am J Respir Crit Care Med 2000; 161:1237–1240.
   PubMed Web of Science ®Google Scholar
• Deykin AA, Halperno O, Massaro AF, Drazen JM, Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med 1998; 157:769–775.
   PubMed Web of Science ®Google Scholar
• Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C, Caramori M, McClean P, Slutsky AS, Zamel N, Chapman KR. Exhaled nitric oxide after β2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med 1999; 159:940–944.
   PubMed Web of Science ®Google Scholar
• Maniscalco M, Vatrella A, Pelaia G, Ricciardolo FLM, Sofia M. Inhaled ultrasonically nebulized distilled water decreases exhaled nitric oxide in asthma. Lung 2003; 180:319–326.
   Google Scholar
• Ojoo JC, Mulrennan SA, Kastelik JA, Morice AH, Redington AE. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005; 60:22–26.
   PubMed Web of Science ®Google Scholar
• Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airways diseases. Am J Respir Crit Care Med 2002; 165:1364–1370.
   PubMed Web of Science ®Google Scholar